GlassScriptPhysician profile
Marty Scheinberg
NPI 1215037726
$3,117.67
in general payments reported to CMS, 2019-2025
33 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $249 · 2021: $392 · 2022: $416 · 2023: $502 · 2024: $620 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,475.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $582.47 | 2019-2024 | Botox |
| Astellas Pharma US INC | $388.86 | 2019-2023 | Veozah |
| Sumitomo Pharma America, INC. | $282.46 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $274.67 | 2019-2024 | |
| Boston Scientific Corporation | $190.91 | 2021-2025 | Rezum Generator, General - Erectile Dysfunction, General - Female Sui |
| Janssen Biotech, INC. | $185.49 | 2019-2022 | |
| Urogen Pharma, INC. | $160.15 | 2024-2025 | |
| Procept Biorobotics Corporation | $151.38 | 2021-2024 | Aquabeam System |
| Pfizer INC. | $105.40 | 2019-2024 | |
| Tolmar, INC. | $74.58 | 2023-2024 | |
| Olympus America INC. | $67.35 | 2020-2025 | Olympus, Olympus, Tecoflex |
| Urovant Sciences INC | $64.78 | 2022 | |
| Dornier Medtech America, INC | $54.81 | 2019 | |
| Ferring Pharmaceuticals INC. | $54.08 | 2019-2025 | Adstiladrin |
| Neotract INC. | $49.50 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $45.75 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Teleflex LLC | $45.06 | 2023 | Urolift |
| Endo Pharmaceuticals INC. | $39.57 | 2024 | Xiaflex |
| Dentsply Ih Ab | $34.64 | 2025 | Lofric |
| 180 Medical, INC. | $24.97 | 2023 | |
| Coloplast Corp | $24.06 | 2019-2023 | Speedicath |
| Medtronic, INC. | $23.62 | 2024 | Ligasure |
| Tolmar Pharmaceuticals, INC. | $22.34 | 2022 | |
| Laborie Medical Technologies Corp. | $21.18 | 2024 | Endosheath Technology |
| Rochester Medical Corporation | $19.97 | 2019 | |
| Allergan, INC. | $19.51 | 2022 | |
| Ambu INC. | $18.61 | 2025 | |
| Blue Earth Diagnostics | $18.14 | 2019 | |
| Azurity Pharmaceuticals, INC. | $16.51 | 2025 | Azmiro |
| Abc Home Medical Supply, INC. | $16.32 | 2024 | |
| Endo USA, INC. | $14.25 | 2024 | Xiaflex, Aveed |
| Hollister Incorporated | $13.86 | 2022 | |
| Amgen INC. | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marty Scheinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.